A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)

Recruiting

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(11 sites)

United States

Up0122 105, Santa Monica, California

Up0122 103, South Miami, Florida

Up0122 102, Durham, North Carolina

Up0122 101, Milwaukee, Wisconsin

Canada

Up0122 202, Calgary